Figari IS - Search Results

1

The autocrine production of transforming growth factor-beta 1 during lymphocyte activation. A study with a monoclonal antibody-based ELISA.

Lucas C, Bald LN, Fendly BM, Mora-Worms M, Figari IS, Patzer EJ, Palladino MA. Lucas C, et al. Among authors: figari is. J Immunol. 1990 Sep 1;145(5):1415-22. J Immunol. 1990. PMID: 2384664

2

Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinic.

Shepard HM, Lewis GD, Sarup JC, Fendly BM, Maneval D, Mordenti J, Figari I, Kotts CE, Palladino MA Jr, Ullrich A, et al. Shepard HM, et al. J Clin Immunol. 1991 May;11(3):117-27. doi: 10.1007/BF00918679. J Clin Immunol. 1991. PMID: 1679763 Review.

3

TGF-beta: a possible autocrine immune regulator.

Lucas C, Wallick S, Fendly BM, Figari I, Palladino MA. Lucas C, et al. Ciba Found Symp. 1991;157:98-108; discussion 108-14. doi: 10.1002/9780470514061.ch7. Ciba Found Symp. 1991. PMID: 2070686

4

The involvement of human tumor necrosis factors-alpha and -beta in the mixed lymphocyte reaction.

Shalaby MR, Espevik T, Rice GC, Ammann AJ, Figari IS, Ranges GE, Palladino MA Jr. Shalaby MR, et al. Among authors: figari is. J Immunol. 1988 Jul 15;141(2):499-503. J Immunol. 1988. PMID: 2968403

5

Transforming growth factor-beta 1 (TGF-beta 1) and recombinant human tumor necrosis factor-alpha reciprocally regulate the generation of lymphokine-activated killer cell activity. Comparison between natural porcine platelet-derived TGF-beta 1 and TGF-beta 2, and recombinant human TGF-beta 1.

Espevik T, Figari IS, Ranges GE, Palladino MA Jr. Espevik T, et al. Among authors: figari is. J Immunol. 1988 Apr 1;140(7):2312-6. J Immunol. 1988. PMID: 3280680

6

Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha.

Ranges GE, Figari IS, Espevik T, Palladino MA Jr. Ranges GE, et al. Among authors: figari is. J Exp Med. 1987 Oct 1;166(4):991-8. doi: 10.1084/jem.166.4.991. J Exp Med. 1987. PMID: 3498791 Free PMC article.

7

Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor.

Tartaglia LA, Goeddel DV, Reynolds C, Figari IS, Weber RF, Fendly BM, Palladino MA Jr. Tartaglia LA, et al. Among authors: figari is. J Immunol. 1993 Nov 1;151(9):4637-41. J Immunol. 1993. PMID: 8409424

8

Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies.

Lewis GD, Figari I, Fendly B, Wong WL, Carter P, Gorman C, Shepard HM. Lewis GD, et al. Cancer Immunol Immunother. 1993 Sep;37(4):255-63. doi: 10.1007/BF01518520. Cancer Immunol Immunother. 1993. PMID: 8102322 Free PMC article.

9

Increased transforming growth factor beta expression inhibits cell proliferation in vitro, yet increases tumorigenicity and tumor growth of Meth A sarcoma cells.

Chang HL, Gillett N, Figari I, Lopez AR, Palladino MA, Derynck R. Chang HL, et al. Cancer Res. 1993 Sep 15;53(18):4391-8. Cancer Res. 1993. PMID: 8364935

10

The two different receptors for tumor necrosis factor mediate distinct cellular responses.

Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA Jr, Goeddel DV. Tartaglia LA, et al. Among authors: figari is. Proc Natl Acad Sci U S A. 1991 Oct 15;88(20):9292-6. doi: 10.1073/pnas.88.20.9292. Proc Natl Acad Sci U S A. 1991. PMID: 1718003 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters